Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(3,4-dihydroxyphenyl)-3-(beta-d-glucofuranosyloxy)-5,7-dihydroxy-4h-1-benzopyran-4-one
2. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-d-glucofuranosyloxy)-5,7-dihydroxy
3. Flavone, 3,3',4',5,7-pentahydroxy-, 3-beta-d-glucofuranoside
4. Isoquercetin
5. Isoquercitin
6. Isoquercitroside
7. Isotrifoliin
8. Quercetin 3-(beta-d-glucofuranoside)
9. Quercetin 3-o-beta-d-glucofuranoside
10. Quercetin-3-glucoside
11. Quercetin-3-o-beta-glucoside
12. Quercetin-3-o-glucoside
13. Trifoliin
14. Trifoliin A
1. Isoquercetin
2. 482-35-9
3. Hirsutrin
4. 3-glucosylquercetin
5. Quercetin 3-o-glucopyranoside
6. Quercetin 3-glucoside
7. Isotrifoliin
8. Quercetin 3-d-glucoside
9. Quercetin 3-o-glucoside
10. Quercetol 3-monoglucoside
11. Glucosyl 3-quercetin
12. Contigoside B
13. Quercetol 3-glucoside
14. Quercetin-3-o-glucopyranoside
15. Quercetin-3-o-glucoside
16. Quercetin 3-monoglucoside
17. Quercetin 3-beta-glucoside
18. Quercetin-3-glucoside
19. Quercetin 3-beta-o-glucoside
20. Quercetin Glucoside
21. Quercetin-3-glucose
22. Ronacare Isoquercetin
23. Glucosyl-3-quercetin
24. Isoquercetin, (-)-
25. 3-beta-d-glucosylquercetin
26. Quercetin 3.beta.-glucoside
27. 6hn2pc637t
28. Chembl250450
29. Chebi:68352
30. 3,3',4',5,7-pentahydroxyflavone 3-beta-glucoside
31. Quercetin 3-o-.beta.-d-glucopyranoside
32. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
33. Quercetin 3-beta-d-glucoside
34. Quercetin 3-o-beta-d-glucopyranoside
35. Nsc-115918
36. Nsc-407304
37. Quercetin 3-o-beta-d-glucoside
38. 2-(3,4-dihidroxyphenyl)-3-(beta-d-glucofuranosyloxy)-5,7-dihydroxy-4h-1-benzopyran-4-one
39. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
40. Smr000466391
41. Nsc 115918
42. Brn 0100989
43. Hydroside
44. Unii-6hn2pc637t
45. Ccris 9340
46. Isoquercitrin (6)
47. Mfcd00017746
48. Acacia
49. 3-glucoside Isoquercitrin
50. Quercetin 3--d-glucoside
51. Isoquercitrin [mi]
52. Isoquercetin [inci]
53. Quercetin 3-glucopyranoside
54. Quercetin 3-ss-d-glucoside
55. 4-18-00-03493 (beilstein Handbook Reference)
56. Mls000759532
57. Mls001424096
58. Q 5
59. Schembl181306
60. Acon1_002134
61. Cid_5280804
62. Cid_5378597
63. Quercetin 3- Beta -d-glucoside
64. Quercetin 3-o--d-glucofuranoside
65. Bdbm153265
66. Hms2051b17
67. Quercetin-3-o-beta-glucopyranoside
68. Hy-n1445
69. Zinc4096845
70. Bdbm50241354
71. Pdsp1_001363
72. Pdsp2_001347
73. S3842
74. Akos015896729
75. Ccg-100967
76. Db12665
77. Nc00217
78. Quercetin-3-o-beta-d-galactopyranoside
79. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl Beta-d-glucopyranoside
80. 4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(3,4-dihydroxyphenyl)-3-(beta-d-glucopyranosyloxy)-
81. 4h-1-benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3-(b-d-glucopyranosyloxy)-5,7-dihydroxy-
82. Quercetin -3-o-beta-d-galactopyranoside
83. As-35335
84. Quercetin-3-o-.beta.-d-glucoside
85. Quercetin 3-glucoside, Analytical Standard
86. Quercetin-3-.beta.-glucopyranoside
87. 3-o-.beta.-d-glucopyranosylquercetin
88. Cs-0016884
89. C05623
90. Quercetin 3-o-glucopyranoside [who-dd]
91. Ab00639942-06
92. Quercetin 3-beta-d-glucoside, >=90% (hplc)
93. 3,3',4',5,7-pentahydroxyflavone 3-a-glucoside
94. A871939
95. 3-glucopyranosyloxy-3',4',5,7-tetrahydroxyflavone
96. Q-100268
97. Q6086296
98. Brd-k73991644-001-01-7
99. 3,3'',4'',5,7-pentahydroxyflavone-3-beta-o-glucoside
100. Isoquercitrin, Primary Pharmaceutical Reference Standard
101. Quercetin 3-o-glucoside (constituent Of Ginkgo) [dsc]
102. 3',4',5,7-tetrahydroxyflavone-3-.beta.-d-glucopyranoside
103. 2-(3,4-dihydroxyphenyl)-3-(beta-d-glucopyranosyloxy)-5,7-dihydroxy-4h-1-benzopyran-4-one
104. 2-hydroxy-4-(3,5,7-trihydroxy-4-oxo-4h-chromen-2-yl)phenyl B-d-glucopyranoside
105. 2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one
106. 2-(3,4-dihydroxyphenyl)-3-(b-d-glucopyranosyloxy)-5,7-dihydroxy-4h-1-benzopyran-4-one, 9ci
107. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
108. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
109. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
110. 4h-1-benzopyran-4-one, 2- (3,4-dihydroxyphenyl)-3- (ss-d-glucofuranosyloxy)-5,7-dihydroxy-
111. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxy-phenyl)-3-(.beta.-d-glucofuranosyloxy)-5,7-dihydroxy-
112. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-d-glucopyranosyloxy)-5,7-dihydroxy-
113. Hw2
| Molecular Weight | 464.4 g/mol |
|---|---|
| Molecular Formula | C21H20O12 |
| XLogP3 | 0.4 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 4 |
| Exact Mass | 464.09547607 g/mol |
| Monoisotopic Mass | 464.09547607 g/mol |
| Topological Polar Surface Area | 207 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 758 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A ACACIA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ACACIA, including repackagers and relabelers. The FDA regulates ACACIA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ACACIA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ACACIA supplier is an individual or a company that provides ACACIA active pharmaceutical ingredient (API) or ACACIA finished formulations upon request. The ACACIA suppliers may include ACACIA API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ACACIA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ACACIA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ACACIA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ACACIA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ACACIA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ACACIA suppliers with NDC on PharmaCompass.
ACACIA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ACACIA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ACACIA GMP manufacturer or ACACIA GMP API supplier for your needs.
A ACACIA CoA (Certificate of Analysis) is a formal document that attests to ACACIA's compliance with ACACIA specifications and serves as a tool for batch-level quality control.
ACACIA CoA mostly includes findings from lab analyses of a specific batch. For each ACACIA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ACACIA may be tested according to a variety of international standards, such as European Pharmacopoeia (ACACIA EP), ACACIA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ACACIA USP).
LOOKING FOR A SUPPLIER?
